• Your search
    starts here.

    Whether you're looking for answers or a second opinion, put one of the world's leading cancer care centers to work for you.


    Search adult cancer typesSearch pediatric cancer types  

    Make an appointment
    with our care specialists.

    Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

    Adult 877-442-3324

    Pediatric 888-733-4662

    Make an Appointment Online  
  • flex image

    Innovation

    Ground-breaking research
    starts on our grounds.

    For 70 years, we’ve led the world by making life-changing breakthroughs in cancer research and patient care. Each year, patients cross the globe to receive the most advanced care available, including over 700 innovative clinical trials. Our sole mission is to defeat cancer, especially yours.

    Research at dana-farber
    Find a Clinical Trial  

Newsroom

Richard Stone, MD

Backed by Dana-Farber research, FDA approves new AML drug

April 28, 2017

The targeted drug midostaurin (Rydapt®), whose clinical testing was led by Dana-Farber's Richard Stone, MD, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.

 

Blog

stem cells illustration

Autologous vs. Allogenic Stem Cell Transplants: What's the Difference?

Two of the most common types of stem cell transplants are autologous and allogeneic transplants. Both kinds of stem cell transplantations are a common treatment option for cancers such as leukemia, lymphoma, and multiple myeloma.

 

Research

Precision Cancer Medicine - Nikhil Wagle, MD

Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.